Inhibition of Angiogenesis by a New Isocoumarin, NM-3.

Takashi Nakashima(Merck & Co., Inc., Rahway, NJ, USA (United States)), TOMIO TAKEUCHI(Microbial Chemistry Research Foundation), Masaaki Ishizuka(Microbial Chemistry Research Foundation), TAKEO YOSHIOKA(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shin‐ichi Hirano(Unknown), KUNIO ISSHIKI(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hiroyuki Kumagai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kenji Maeda(Microbial Chemistry Research Foundation), Naoki Agata(Merck & Co., Inc., Rahway, NJ, USA (United States))
The Journal of Antibiotics
January 1, 1999
10.7164/antibiotics.52.426
Cited by 36

Related Papers

Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes
|Scientific Reports|2014|130
Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats
|Inflammation Research|2005|104
Hydrogen-Rich Saline Regulates Intestinal Barrier Dysfunction, Dysbiosis, and Bacterial Translocation in a Murine Model of Sepsis
|Shock|2017|79
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
|PubMed|1977|79
Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
|PubMed|1997|76